DNA vaccines offer clear advantages over traditional vaccines, and our company is fully committed to providing top-tier services for DNA vaccine development. Our goal is to empower you with advanced technologies and comprehensive support, enabling you to maximize the potential of DNA vaccines and contribute to the advancement of global healthcare.
DNA Vaccines and Immune Mechanisms
A DNA vaccine is a type of vaccine that transfects specific antigen-encoding DNA sequences into cells of an organism to induce an immune response. DNA vaccines represent a revolutionary immunization approach with tremendous potential in preventing infectious diseases.
How Do DNA Vaccines Work?
After the vaccine enters the human body, the plasmid DNA enters the host cells and is absorbed by the cell nucleus. Inside the nucleus, the DNA is transcribed into mRNA, which is then translated into antigen proteins. Once the antigen proteins are presented to immune cells, they trigger an immune response, activating various immune cells and generating antigen-specific antibodies.
Fig. 1 A scheme for the mechanisms of immune activation by DNA vaccines. (Huang T, et al., 2022)
Delivery Methods of DNA Vaccines
DNA vaccines can be administered through various methods, such as intramuscular injection, intradermal injection, electroporation, gene gun, oral administration, or intranasal administration. The following focuses on electroporation, gene gun, and oral or intranasal administration.
Electroporation
Electroporation is a technique that enhances DNA vaccine delivery by creating temporary pores in the cell membranes. After injecting the DNA vaccine into the target tissue, an electric field is applied to the area, causing the cell membranes to become more permeable.
Gene Gun
Gold or tungsten particles coated with the DNA vaccine are propelled at high speeds into the target tissue using compressed gas. The particles penetrate the cells, delivering the DNA vaccine directly into the nucleus. This method is suitable for delivering DNA vaccines to the skin or mucosal surfaces.
Oral or Intranasal Administration
Oral administration involves the ingestion of a DNA vaccine in the form of a drink or capsule, while intranasal administration involves delivering the vaccine through a nasal spray or droplets. These routes target the immune cells in the mucosal tissues, including the respiratory and digestive tracts.
Challenges in DNA Vaccine Development
The development of DNA vaccines faces several challenges that researchers and scientists strive to overcome. These challenges include:
- Delivery Efficiency
The DNA needs to reach the nucleus of the target cells for successful transcription and translation of the antigenic protein. Optimizing delivery efficiency is an ongoing challenge in DNA vaccine development.
- Immunogenicity
DNA itself is not inherently immunogenic. To enhance the immune response, researchers incorporate adjuvants, optimize antigen design, and select appropriate promoters and enhancer sequences.
- Stability and Storage
DNA vaccines are sensitive to degradation, particularly by nucleases present in body fluids. Ensuring the stability of DNA vaccines during storage and transportation is crucial.
- Manufacturing and Scale-up
The production of DNA vaccines involves complex processes. Developing scalable and cost-effective manufacturing processes while maintaining product consistency and quality is crucial for the widespread availability of DNA vaccines.
Our Services
DNA vaccines have revolutionized the field of infectious disease prevention, offering immense potential. Our company is dedicated to delivering top-notch services aimed at accelerating the development and commercialization of DNA vaccines.
DNA Vaccine Development Process
Antigen Selection
Our scientists achieve this by studying pathogen biology and analyzing genetic sequences to help determine the specific antigens targeted by DNA vaccines.
DNA Design
Once the antigen is selected, the DNA sequence encoding the antigen is designed and synthesized.
Plasmid DNA Construction
The designed DNA sequence is inserted into a plasmid vector, which serves as a carrier for the DNA vaccine.
Formulation Development
This involves the addition of adjuvants and optimization of ingredients to improve vaccine stability and immune response.
Delivery System Development
Our scientists excel at exploring various delivery systems, such as viral vectors, lipid nanoparticles, or other non-viral systems, to ensure efficient uptake of DNA vaccines by target cells and promote their expression.
Applicable Infectious Disease Types
- Influenza
- Zika Virus
- Dengue Fever
- Human Immunodeficiency Virus (HIV)
- Malaria
- Tuberculosis
- Hepatitis B
- Human Papillomavirus (HPV)
- Coronavirus Disease 2019 (COVID-19)
- And More
Our company is dedicated to pushing the boundaries of DNA vaccine development. If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
References
- Huang T, Liu L, Lv Z, et al. Recent advances in DNA vaccines against lung cancer: A mini review[J]. Vaccines, 2022, 10(10): 1586.
- Lim M, Badruddoza A Z M, Firdous J, et al. Engineered nanodelivery systems to improve DNA vaccine technologies[J]. Pharmaceutics, 2020, 12(1): 30.
All of our services and products are intended for preclinical research use
only and cannot be used to diagnose, treat or manage patients.
